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Grinman DY, Careaga VP, Wellberg EA, Dansey MV, Kordon
EC, Anderson SM, Maier MS, Burton G, MacLean PS, Rudolph
MC, Pecci A. Liver X receptor- activation enhances cholesterol
secretion in lactating mammary epithelium. Am J Physiol Endocrinol
Metab 316: E1136–E1145, 2019. First published April 19, 2019;
doi:10.1152/ajpendo.00548.2018.—Liver X receptors (LXRs) are li-
gand-dependent transcription factors activated by cholesterol metab-
olites. These receptors induce a suite of target genes required for de
novo synthesis of triglycerides and cholesterol transport in many
tissues. Two different isoforms, LXR and LXR, have been well
characterized in liver, adipocytes, macrophages, and intestinal epithe-
lium among others, but their contribution to cholesterol and fatty acid
efflux in the lactating mammary epithelium is poorly understood. We
hypothesize that LXR regulates lipogenesis during milk fat production
in lactation. Global mRNA analysis of mouse mammary epithelial
cells (MECs) revealed multiple LXR/RXR targets upregulated sharply
early in lactation compared with midpregnancy. LXR is the primary
isoform, and its protein levels increase throughout lactation in MECs.
The LXR agonist GW3965 markedly induced several genes involved
in cholesterol transport and lipogenesis and enhanced cytoplasmic
lipid droplet accumulation in the HC11 MEC cell line. Importantly, in
vivo pharmacological activation of LXR increased the milk choles-
terol percentage and induced sterol regulatory element-binding pro-
tein 1c (Srebp1c) and ATP-binding cassette transporter a7 (Abca7)
expression in MECs. Cumulatively, our findings identify LXR as an
important regulator of cholesterol incorporation into the milk through
key nodes of de novo lipogenesis, suggesting a potential therapeutic
target in women with difficulty initiating lactation.
cholesterol pathway; lactation; LXR; mammary epithelial cells; milk
lipid
INTRODUCTION
Newborn nutrition status is a matter of public health concern
because breastfed infants are moderately protected against the
risks of childhood obesity, type 2 diabetes, and infant mortality
(53). For the mother, depending on the duration, lactation is
protective against breast cancer risk, type 2 diabetes, and
possibly obesity (55). Lactation provides a highly specialized
food source that ensures the optimal development of the
neonate, and its composition remains dynamic to sustain the
energy demands of newborn growth with a near perfect blend
of macronutrients (35). Particularly from the neonate’s per-
spective, lipids represent an energy dense nutrient supply used
for efficient synthesis of ATP required during postnatal growth
and development. Moreover, milk lipids are the source of
essential components for building cellular membranes, as well
as the substrate for myelin synthesis essential for proper
nervous system maturation (23).
Milk fat production at the onset of lactation requires the
mammary epithelial cells (MECs) to synchronize tasks in-
cluding exogenous lipid uptake, processing and intracellular
lipid transport, integration with de novo fatty acid synthesis,
and packaging into cytoplasmic lipid droplets (CLDs); ulti-
mately, these biosynthetic pathways converge to secrete a
complex blend of lipids into the alveolar lumen (33). Lac-
tating mammary epithelium is thought to have consolidated
many conserved lipogenic and CLD pathways observed in
other tissues, such as the liver and adipose tissues, and has
evolved specialized regulation of gene expression common
to lipogenesis that is induced in unison at the onset of
lactation (43). The appropriate control of these metabolic
processes, dependent on maternal diet and physiology, de-
termines the milk fatty acid composition that can directly
influence neonatal development (47).
Cholesterol is a critical lipid component of milk, not only
because it supplies the offspring with an important structural
lipid, but also because of its importance in formation of
intracellular CLDs (5). The core of the intracellular CLD
harbors densely packed neutral lipids, including cholesterol
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esters (CEs) and triglycerides (TGs) (12). CEs and TGs within
the mammary gland are synthesized in the endoplasmic retic-
ulum and packaged into CLDs that migrate to and accumulate
at the apical border of mammary acini and are then secreted as
a unique triple membrane structure: the milk fat globule (MFG)
(29, 31, 32, 51). Hence, milk fat production initiates with the
synthesis and incorporation of CEs and TGs into a neutral lipid
core.
Liver X receptors (LXR and LXR) belong to the nuclear
hormone receptor family of transcription factors, which are
known to regulate lipid metabolism and transport in several
tissues (4). Similar to other class II nuclear receptors, LXRs
regulate transcription as a heterodimer together with the reti-
noid X receptor (RXR) (18, 53, 60). In the absence of ligands,
the heterodimer bound to LXR response elements of target
genes recruits corepressors to attenuate transcriptional activa-
tion. Upon the binding of agonists, the receptor undergoes
conformational changes that result in the release of corepres-
sors and the recruitment of coactivators, leading to transcrip-
tional activation. The endogenous LXRs ligands are oxidative
derivatives of cholesterol called oxysterols (17, 18). Increased
intracellular levels of cholesterol lead to a proportionate rise in
the abundance of oxysterols and consequently increase ligand
bound activation of LXRs (49). LXR target genes include the
sterol regulatory element-binding protein 1 (Srebp1), fatty acid
synthase (Fasn), acetyl CoA carboxylase (Aacac), stearoyl
CoA desaturase 1 (Scd1), and some ATP-binding cassette
transporters (Abcs), all of which have been shown to be
important for the de novo synthesis of fatty acids and choles-
terol transport, including during milk production (8, 19, 39, 40,
48, 62).
Several lines of evidence indicate that LXRs play a role in
milk fat synthesis and secretion. LXRs mRNAs were shown to
be expressed in cow and mouse whole gland lysates in preg-
nancy and lactation concomitant with the expression of numer-
ous LXR-responsive cholesterol transporters (9, 11, 27, 28,
45). It has also been shown that stimulation of bovine MECs
with a synthetic LXR agonist (TO901317) leads to an increase
in the de novo synthesis of fatty acids accompanied by in-
creased expression of Srebp1c (11, 25, 30, 37, 57). Previously,
we hypothesized that LXRs directly contribute to milk fat
production during lactation in the mouse (45). Here, we deter-
mined that LXR is the predominant isoform expressed in
isolated MECs and its level increases at midlactation when de
novo fatty acid synthesis is maximal (44). We profiled differ-
entially expressed mRNAs between MECs isolated at preg-
nancy day 14 and lactation day 4 and found an LXR/RXR gene
signature that includes multiple upregulated LXR target genes.
Importantly, short-term pharmacological LXR activation in
the lactating dam increases milk’s cholesterol levels along with
the expression of Abca7 and Srebp1c. These findings reveal a
key role of LXR in cholesterol synthesis during lactation.
MATERIALS AND METHODS
Reagents. Recombinant Human EGF was purchased from Invitro-
gen, insulin was obtained from Novo Nordisk, ovine prolactin and
dexamethasone were from Sigma, GW3965 was from Medchem
Express, and the Compound 1 (CMP1) was prepared as previously
described (1). For culture assays, 1,000 solutions were prepared.
Steroid stock solutions were prepared in dimethyl sulfoxide.
Cell cultures and treatments. HC11 cells, derived from BALB/c
mouse normal mammary glands (3) (kindly provided by Dr. Nancy
Hynes, Friedrich Meischer Institute, Basel, Switzerland), were rou-
tinely grown in RPMI 1640 growth medium (Gibco) supplemented
with 10% FBS (Internegocios), containing 5 g/ml insulin, 10 ng/ml
EGF, 100 IU/ml penicillin, and 100 g/ml streptomycin (Gibco).
Under these growth conditions, proliferating/undifferentiated cells
were obtained. Upon reaching confluence, cells were grown in EGF-
depleted medium (RPMI 1640, 2% FBS, 5 g/ml insulin, 100 IU/ml
penicillin, and 100 g/ml streptomycin) for 72 h to reach competence
(responsiveness to lactogenic stimuli). Functional differentiation of
competent cells was then induced by treatment with 100 nM dexa-
methasone and 1 g/ml prolactin in EGF-depleted medium for 72 h.
Cells were maintained at 37°C in a humidified atmosphere with 5%
CO2.
Lipid droplet analysis. HC11 cells were differentiated in a six-well
plate. Upon reaching differentiation, cells were treated with GW3965
(1 M) and/or the LXR antagonist CMP1 (10 M) for 72 h, washed
three times with 1 PBS, fixed with 4% paraformaldehyde for 20 min
at room temperature, and washed three additional times with PBS.
Afterwards, cells were incubated in a PBS solution containing
BODIPY 493/503 that has affinity for neutral lipids (1g/ml) (Mo-
lecular Probes) for 1 h at 37°C and washed three times with PBS.
Images were acquired with a confocal microscope FV1000 (Olym-
pus), using an immersion oil objective UPlanSApo 60 (NA  1.35).
BODIPY 493/502 was excited using a multiline Ar laser at 488 nm,
and the fluorescence was detected with a photomultiplier. The image
size was 2,048  2,048 pixels2. Ten 210  210 m2 fields were
randomly captured for each biological sample. The images were
binarized and analyzed with the ImageJ software (https://imagej.nih-
.gov/ij/). CLDs total area per field was quantified automatically, and
the number of total cells per field was counted using the Plug In “cell
counter.” The results are expressed as the average value of the total
area of fluorescent CLDs (m2) in each field and divided by the
number of cells in the respective field, as described by Ref. 34.
Animals. C57BL/6j mice were housed in a pathogen-free temper-
ature-controlled environment on a 12:12-h light-dark cycle (lights on
6:30 AM–6:30 PM, 21°C) and fed a standard laboratory chow diet
and water ad libitum. Experimental procedures were approved by the
Ethics Committees for Animal Experiments of the University of
Buenos Aires (Protocol No. 100) and performed in accordance with
the standard international animal care protocols (Canadian Council of
Animal Care’s 1980 Guide to the Care and Use of Experimental
Animals) (CCAC, 1980). Females were mated with males of the same
genetic background at 10 wk old. Litters were standardized to six to
eight pups for all studies. Pregnancy day 1 (P1) was designated as the
day vaginal plug was observed, and lactation day 1 (Lac1) was the day
that pups were born. In all experiments, animals were euthanized by
cervical dislocation.
Milk collection and milk lipids analysis. Milk was collected as
described by Schwertfeger et al. (50). Briefly, on Lac10 females were
separated from their pups 3 h prior milk collection to allow milk
accumulation. Before milking, mice were anesthetized with xylazine
(8 mg/kg; Sigma) and ketamine (90 mg/kg; Sigma) and the intraperi-
toneally injected with 2 units of oxytocin (Sigma) to induce milk let
down. The milk was immediately collected from the mammary glands
using gentle vacuum suction with a device adapted from Ref. 10 and
frozen at 80°C till lipid analysis. For analysis of fat content, whole
milk was drawn into capillary tubes and centrifuged at 3,000 rpm for
20 min. The amount of fat collected into the top layer was calculated
as a percentage of the total material present in the tube. Milk lipids
were extracted from 10 mg freeze-dried samples by chloroform:
methanol extraction following the method of Bligh and Dyer (6). To
determine the fatty acid composition, fatty acid methyl esters (FAME)
were prepared by reaction with 5% HCl in methanol at 70°C for 2 h.
After cooling, water was added and FAME were extracted with
chloroform. Approximately 1–2 mg of FAME were weighed into
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individual vials followed by the addition of internal standard methyl
nonadecanoate (C19:0) and analyzed by gas chromatography-mass
spectrometry on a Shimadzu GCMS-QP5050 A instrument equipped
with a ZB-5 (Phenomenex) column (30 m  0.25 mm inner diameter,
0.50-m thickness). Helium was used as carrier gas (0.9 ml/min flow
rate). The injector was set a 250°C, and the detector was set at 280°C.
Column temperature was programmed to increase from 100 to 200°C
at a rate of 6°C/min followed by an isothermal period of 1 min and
then heated to 280°C at a rate of 2°C/min followed by an isothermal
period of 30 min. Compound identifications were carried out by
comparing retention times of FAME standards (Sigma) and mass
spectrometric fragmentation patterns. Quantitation was performed by
comparing the percentage area of each FAME peak on the chromato-
gram with that of the internal standard (methyl nonadecanoate;
Sigma) of known weight and expressed as percentage of total fatty
acids.
Quantification of milk cholesterol. To quantify total cholesterol, an
aliquot of 2–7 mg of the lipid samples was saponified with 4%
potassium hydroxide in an ethanolic aqueous solution (2:1, vol/vol) at
60°C for 2 h. After cooling at room temperature, the neutral fraction
was extracted with n-hexane. After addition 5–10 g of stigmasterol
95% (Sigma) as internal standard, trimethylsilyl derivatives of the
neutral fraction were prepared by addition of 20 l of N,O-bis(trim-
ethylsilyl)triflouroacetamide with 1% trimethylchlorosilane (Supelco)
and heating at 60°C for 20 min. After cooling, the trimethylsilyl
derivatives derivatives were dried under a soft stream of nitrogen,
dichloromethane was added, and the solution was stored at 4°C.
Samples were analyzed by gas chromatography-mass spectrometry
within 24 h of derivatization. Helium was used as carrier gas (1
ml/min flow rate). The injector was set a 250°C, and the detector was
set at 280°C. Column temperature was programmed to increase from
240°C to 200°C at a rate of 10°C/min followed by an isothermal
period of 25 min and then heated to 290°C at a rate of 8°C/min
followed by an isothermal period of 30 min.
Enrichment of MECs from whole mammary glands. MECs were
prepared using a modified version of the previously described proto-
col (44). The mammary digestion buffer was prepared and included
Kreb-Ringer-HEPES buffer (containing the following in mM: 120
NaCl, 4.7 KCl, 2.2 CaCl2, 10 HEPES, 1.2 KH2PO4, and 1.2 MgSO4),
2 mg/ml collagenase A (Roche) and 0.5 mg/ml hyaluronidase
(Sigma). Upon animal euthanasia, mammary glands no. 4 and 5 were
excised and lymph nodes were removed. Scalpels were used to dice
the glands into a fine paste, which were then digested in 10 ml of
digestion buffer for 1 h at 37°C in a 200 rpm a shaker. The digested
cell suspension was spun at 300 g for 3 min and washed three times
with ice cold Kreb-Ringer-HEPES buffer. Half of the samples were
used for RNA analysis and half for protein analysis. Samples were
homogenized using an Ultraturrax T25 (Ika Labortechnik, Staufen,
Germany), and lysate was centrifuged at 13,000 g for 10 min at 4°C.
The isolation procedure reduced the adipocyte marker Perilipin
(PLIN) by almost 98%, indicating that the MECs were highly en-
riched for the epithelial cell population (Supplemental Fig. S1: https://
doi.org/10.6084/m9.figshare.7469933.v2).
Protein analysis. Protein extract from the HC11 cells and the
MEC-enriched lysate was prepared in RIPA lysis buffer [containing
20 mM Tris·HCl pH 7.4, 137 mM NaCl, 2 mM EDTA, 10% glycerol,
1% Triton X-100, 0.5% deoxycholate, and 0.1% SDS] containing 50
mM NaF, 1 mM Na3VO4, and protease inhibitor cocktail (Promega).
Lysates were centrifuged at 13,000 g for 10 min at 4°C. Protein
concentrations were determined using the Bradford Protein Assay.
Proteins were then resolved using SDS-polyacrylamide gels (8–12%).
Resolved proteins were transferred to an Amersham Hybond P 0.45
PVDF blotting membrane (GE Healthcare Life Sciences) and immu-
noblotting was carried out using the Amersham Imager 600RGB (GE
Healthcare Life Sciences). The following primary antibodies were
used: LXR (ab106464) and LXR (ab24361; Abcam, Cambridge,
UK) and HSP90 (no. 4874; Cell Signaling Technology, Beverly,
MA).
RNA isolation and RT-real time PCR. HC11 samples were lysated
in 500 l TRIzol (Invitrogen) while mammary gland derived MECs
were homogenized in 1 ml TRIzol using an Ultraturrax T25 (Ika
Labortechnik). Lysates were cleared at 13,000 g for 10 min at 4°C.
The RNA was isolated according to the manufacturer’s instructions.
Total RNA was quantitated using the Nanodrop 1000 spectrophotom-
eter (Thermo Fisher Scientific). For all samples, the ratio of absor-
bance at 260 nm to absorbance at 280 nm was 	1.8. For quantitative
real-time PCR analysis, cDNA was synthesized using 1 g of total
RNA and 200 units of the Moloney Murine Leukemia Virus Reverse
Transcriptase Enzyme (Promega) in 20 l of total volume according
to manufacturer’s instructions. For the quantitative PCR the cDNA
was diluted to 20 ng/ul, and 5 l of the diluted cDNA was used per
reaction. All reactions were conducted in a volume of 25 l contain-
ing 2–4 mM MgCl2 (Invitrogen), 0.2 mM dNTPs (Invitrogen), 0.8
mM of the primer pair, 0.625 U Taq polymerase (Invitrogen), and
0.025 l of a 1/30,000 Sybr Green (Roche, Indianapolis, IN) dilution.
Quantitavie PCR data were collected on the StepOnePlus Real-Time
PCR System (Thermo Fisher Scientific). Primer sequences are avail-
able on request. PCR products representing the unique product (the
amplicon) for each gene were amplified from cDNA as above, and
amplicons were purified using QIAquick PCR Purification Kit (Qia-
gen). Concentrations of purified double stranded amplicons for each
gene were measured using the NanoDrop 1000 spectrophotometer
(Thermo Fisher Scientific). mRNA copy numbers were calculated
using each amplicon standard regression curve from the known
quantity of the amplicon as previously described (46).
Global gene expression profiling. Microarray data were generated
and analyzed as previously described (42, 58). Briefly, 250 ng of total
RNA were used as input to the Whole-Transcript Expression RNA kit
(Life Technologies, Carlsbad, CA), samples were hybridized to mouse
1.1 ST Gene Arrays (Affymetrix, Santa Clara, CA), and arrays were
washed, stained, and imaged using the Affymetrix GeneAtlas Per-
sonal Microarray System. Raw data were gas chromatography-robust
multiarray averaging normalized and log2 transformed, and statistics
were performed using the Partek Genomic Suite (Partek, St. Louis,
MO). Significant and differentially expressed genes were uploaded to
Ingenuity Pathway Analysis Software (Qiagen) for biological inter-
pretation. Data can be accessed through the NCBI GEO using
GSE121819.
Statistical analysis. Results were expressed as means 
 SE of at
least 3 independent experiments. Statistical analyses were performed
with STATISTICA 6.0 (StatSoft) and consisted of one-way ANOVA
followed by Tukey’s or Dunnett’s multiple comparisons tests as
indicated in the figure legends. Before statistical analysis, Q-Q plot
and Shapiro Wilks test were performed for normality. Homoscedas-
ticity was assessed with Levene’s test. In figures, different letters or
asterisks mean significant differences (P  0.05) between means or
versus control, respectively. For microarray analysis, one-way
ANOVA followed by Bonferroni multiple comparisons test with a
false discovery rate of 0.01 was performed using Partek Genomics
Suite version 6.6 software (Partek, St. Louis, MO).
RESULTS
Lipogenic genes and LXR expression are upregulated in
mammary epithelial cells during lactation. Two principle
stages of the mammary gland were analyzed by global gene
expression profiling using isolated MECs, functional differen-
tiation at P14 and copious milk production at Lac4. With the
use of a 1.3-fold cutoff and a false discovery rate multiple
testing significance of 0.025, 	2,400 genes were differentially
expressed. This list of significantly changed transcripts was
used to seed Ingenuity Pathway Analysis to identify key
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pathways involved in the MECs transition from P14 to Lac4.
Notably, the enzymatic superpathway for cholesterol biosyn-
thesis (Fig. 1A) and the mRNA signature for LXR/RXR acti-
vation had strong positive z-scores (activated) using an unsu-
pervised method (Supplemental Table S1: https://doi.org/
10.6084/m9.figshare.7471178.v1). Several lipogenic genes
were upregulated in Lac4 MECs relative to P14, many of
which are involved in the cholesterol biosynthetic pathway,
including acetyl-Co A acetyltransferase 2 (Acat2), mevalonate
(diphospho) decarboxylase (Mvd), mevalonate kinase (Mvk),
phosphomevalonate kinase (Pmvk), 3-hydroxy-3-methylglu-
taryl-Coenzyme A synthase 1 (Hmgcs1), 3-hydroxy-3-methyl-
glutaryl-coenzyme A reductase (Hmgcr), squalene epoxidase
(Sqle), lanosterol synthase (Lss), isopentenyl-diphosphate
delta isomerase (Idi1), farnesyl diphosphate farnesyl trans-
ferase 1 (Fdft1), farnesyl diphosphate synthetase (Fdps), 24-
dehydrocholesterol reductase (Dhcr24) and 7-dehydrocholes-
terol reductase (Dhcr7). Moreover, the expression of Ldl re-
ceptor and Lrp8, which mediate cholesterol uptake also
increased, while the ATP-binding cassette transporters in-
volved in cholesterol secretion (Abca1 and Abcg1) decreased,
suggesting that cholesterol loading of MECs happens early in
lactation (Fig. 1A). While genes involved in fatty acid break-
down (i.e., Hadha/b and Hmgcs2) were also decreased, expres-
sion of known LXR target genes that participate in the de novo
synthesis and transport of fatty acids (i.e., Lpl, Acaca, Fasn,
Cd36 and Scd1) were upregulated, supporting the involvement
of the LXR pathway with potential regulation of the lipogenic
program of MECs during lactation.
The protein level of the LXRs was evaluated by Western
blot analysis specifically in adipocyte-depleted MECs from late
pregnant mice and at multiple time points throughout lactation.
LXR protein was expressed in P17 MECs and its levels rose
consistently to midlactation, reaching significance by Lac10
relative to P17 (Fig. 1B, Up). Additionally, the nuclear local-
ization of LXR was confirmed in MECs from Lac4 dams
(Supplemental Fig. S1: https://doi.org/10.6084/m9.figshare.
7469933.v2). LXR protein was undetectable in all samples
analyzed (Grinman, DY, unpublished observation), supporting
a role of for LXR as the primary isoform in the mammary
epithelium. This observation was further reinforced by the
significantly lower (4.81 
 0.24-fold) abundance of Lxr
mRNA copy number compared with Lxr in Lac10 MECs
(Fig. 1B, Down).
LXR activation increases cytoplasmic lipid droplet accu-
mulation. A well-established mammary epithelial cell line
HC11 was used to address whether LXR activation stimulates
lipogenesis in vitro. The predominant LXR isoform expressed in
differentiated HC11 cells is Lxr (Supplemental Fig. S2: https://
doi.org/10.6084/m9.figshare.7471505.v1), with the mean tran-
Fig. 1. Liver X receptor- (LXR) is the
prominent isoform upregulated during lacta-
tion in isolated mammary epithelial cells. A:
global mRNA profiling of isolated mam-
mary epithelial cells (MECs) indicates mul-
tiple components of the cholesterol biosyn-
thesis superpathway are robustly upregu-
lated between functional differentiation in
pregnancy [pregnant day 14 (P14)] and fol-
lowing secretory activation in established
lactation [lactation day 4 (L4)] (n  4 per
time point; 1-way ANOVA, multiple testing
correction false discovery rate P  0.025).
B, top: LXR protein levels measured along
a time series in isolated MEC fractions from
late pregnancy (P17) to mid-lactation (Lac10)
dams (n  5 per time point; representative
immunoblot in duplicate MEC preparations
is shown below with HSP90 as the loading
control). B, bottom: absolute mRNA copy
number for LXR and LXR quantified in
50 ng of cDNA from Lac10 MECs. In all
cases, bars are means 
 SE. Bars with dif-
ferent letters or *P  0.05 are significantly
different.
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script copy number ~3,000-fold higher than that of Lxr in each
of the three differentiation stages. This observation in HC11 cell
culture is consistent with the difference observed in vivo from
isolated MECs and supports a role for the LXR isoform in
mammary epithelial cells. To evaluate the effects of LXR
activation in differentiated HC11, cells were treated with the
LXR agonist GW3965. Levels of mRNAs for the Srebp1c
transcription factor and Abca1 transporter significantly in-
creased upon ligand stimulation under fully differentiated con-
ditions (Fig. 2), whereas the mRNA levels of Abca7, Fasn,
Acly, Acaca, Slc25a1, Ppar, and Npc1 remain unchanged.
Moreover, LXR activation enhanced the mean CLD area by
33% (Fig. 3), indicating the in vitro induction of lipogenesis in
MECs over 72 h of treatment. GW3965 dependent CLD
accumulation was completely blocked in the presence of
LXR antagonist CMP1 with GW3965 treatment. Treatment
with CMP1 alone did not affect the CLDs accumulation,
suggesting that this compound does not alter CLD stability
per se.
LXR activation promotes milk cholesterol secretion dur-
ing lactation. In vivo, lactation day 9 dams treated with the
LXR agonist GW3965 acutely for 24 h had significantly
upregulated LXR (Fig. 4), indicating possible autoregula-
tion of the LXR promoter in MECs. Moreover, the Abca7
cholesterol transporter was significantly induced following
24 h in vivo GW3965 treatment, potentially identifying a
novel LXR target gene in MECs. Consistent with differen-
tiated HC11 cells, the transcription factor Srebp1c was
Fig. 2. In vitro liver X receptor- (LXR) activation induces
the expression of sterol regulatory element-binding protein 1c
(SREBP1c) and ATP-binding cassette A1 (ABCA1) genes.
Abundance of different ABC transporters and lipogenic genes
were measured by quantitative RT-PCR from differentiated
HC11 cells treated with GW3965 (1 M) or vehicle (DMSO)
for 6 h. Copy number of each gene relative to rRNA18s is
plotted as the ratio to the mean of all samples for each gene to
display expression levels on a comparable scale. Bars are
means 
 SE (*P  0.05, n  3).
Fig. 3. Liver X receptor- (LXR) activation enhances cytoplasmic lipid droplets accumulation in differentiated HC11 cells. Differentiated HC11 cells were
incubated with vehicle (VEH.), LXR agonist GW3965 (1 M), LXR antagonist Compound 1 (CMP1) (10 M), or both (GW3965  CMP1) for 72 h and then
stained with BODIPY 493/503. (A) Representative confocal images. B: quantification of the cytoplasmic lipid droplet (CLD) area. Values are expressed as
means 
 SE of the total area of fluorescent CLDs (m2) in each field divided by the number of cells in the respective field counted manually using the ImageJ
Plug In “cell counter.” Treatments with different letters are significantly different (P  0.05, n  3).
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markedly upregulated in vivo, and de novo fatty acid syn-
thesis pathway genes Acly, Acaca, and Slc25a1 tended to
increase at 24-h following a single dose of GW3965 treat-
ment in lactating dams.
The acute LXR activation significantly increased the per-
centage of total cholesterol (2.6 
 0.4-fold) in the milk fat
(Fig. 5A), indicating that activated LXR can enhance choles-
terol incorporation into the milk. Based on the sharp induction
of Srebp1c and increasing trend for de novo fatty acid synthesis
enzyme genes, we hypothesized that GW3965 stimulation of
LXR would increase the proportion of de novo-derived me-
dium chain fatty acids in the milk lipids. Unexpectedly, acute
GW3965 administration did not influence the milk fatty acid
profile (Fig. 5B) nor the relative abundance of medium chain
fatty acids (Fig. 5B, inset). Consistent with this observation,
levels for FASN mRNA (Fig. 4) and protein (Grinman, DY,
unpublished observation) were unchanged in isolated MECs
following acute GW3965 treatment. Additionally, preformed
fatty acid composition did not vary in the milk fat, suggesting
24 h following a single dose of GW3965 did not influence their
uptake and incorporation into TG. The increased milk choles-
terol following GW3965 treatment was independent of the total
milk fat at ~25% of milk volume (Fig. 5C, left), which was
supported by the dry mass of total lipid per mass of wet milk
(Fig. 5C, right), indicating acute GW3965 treatment did not
affect the total milk fat amount.
DISCUSSION
During lactation, the functional mammary gland is charged
with the essential task to synthesize and secrete energy dense
lipids in the form of TG and CEs. Several studies have shown
coordinated induction of genes involved in cholesterol and
fatty acid synthesis occurring at the transition between func-
tional differentiation of MECs in pregnancy and secretory
activation that triggers copious milk fat production in mice (2,
13, 43, 45). Previous evidence regarding levels of LXR mRNA
and protein patterns in the mammary gland, particularly in
MECs, has been inconsistent. Here, we provide strong evi-
dence for the MEC-specific contribution of activated LXR in
the regulation of cholesterol incorporation in milk fat during
established lactation in mice.
In line with previous findings (2, 13, 41, 44, 45), we
observed a robust induction of lipogenic genes between func-
tionally differentiated MECs (P14) and MECs undergoing
copious milk fat synthesis (L4). During mouse peak lactation
(Lac10), the energy demands for maintaining growth of the
litter become maximal, and lipids provide on average more
than 80% of the energy available to the young (21). For
example, de novo fatty acid synthesis reaches its highest point
at Lac10 (44), which coincides with the maximal LXR levels
we observed in MECs progressively from late pregnancy (P17)
to peak lactation (Lac10). Acute administration of synthetic
LXR agonist GW3965 at Lac9 strongly upregulated Srebp1c
and tended to enhance expression of Acly, Acaca, and Slc25a1,
suggesting a possible feed-forward loop to balance uptake of
cholesterol with de novo fatty acid levels during TG synthesis.
Although acute treatment of Lac9 dams with GW3965 in-
creased milk total cholesterol ~2.6-fold, which was coincident
with a previously undescribed MECs-specific upregulation of
Abca7 (Fig. 3B), we observed no effect ( 7% increase, P 
0.2) on de novo or preformed fatty acid composition.
Others have shown that ABCA7 protein was expressed
abundantly in the MECs at peak lactation in mice (Lac9–12),
with a generalized cellular localization that was neither apical
or basal (27). Although the exact function(s) of ABCA7 are not
well defined, ABCA7 activity has been connected with cellular
efflux pathways for cholesterol and phospholipids as well as
lipoprotein particle binding (20). ABCA7 stimulates diffusion-
mediated cholesterol release mainly to a partially lipidated
discoidal form of APOE (7), while ABCA1 is an essential
molecule for HDL generation and mediates cholesterol efflux
to lipid-free acceptors, such as APOA-1 and APOE (38, 56).
These differences, along with the observation that liver-spe-
cific LXR targets Abca1 and Abcg1 are downregulated,
underscores a possible mammary specific adaptation for LXR
function during lactation such as cholesterol loading. Collec-
tively, we propose that the LXR/RXR pathway reinforces
cholesterol and de novo fatty acid pathways during peak
lactation, in part by Abca7 and Srebp1c induction, ensuring
milk lipids are balanced and TG synthesis is sufficient to meet
the energy and structural lipid demand for neonatal growth.
This idea is further supported by our observation that LXR
activation increased accumulation of CLD, which could be ac-
companied by an enrichment of cholesterol inside these structures,
resulting in more cholesterol secreted within the MFGs. If such
enrichment takes place, it is likely mainly due to intracellular
Fig. 4. Liver X receptor- (LXR) activation induces the
expression of ATP-binding cassette A7 (ABCA7) and sterol
regulatory element-binding protein 1c (SREBP1c) in vivo.
Abundance of different ABC transporters and lipogenic
genes were measured by quantitative RT-PCR from isolated
mammary epithelial cells (MECs) following 24 h of either
GW3965 (30 mg/kg) or vehicle (10% DMSO in saline) at
lactation day 9. Copy number of each gene relative to
rRNA18s is plotted as the ratio to the mean of all samples
for each gene to display expression levels on a comparable
scale. Bars are means 
 SE (*P  0.05, n  5).
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cholesterol redistribution toward the lipid droplets (24), rather
than an increase in the de novo cholesterol synthesis, since we did
not detect differential expression levels of sterol response ele-
ment-binding protein 2, a key regulator of sterol synthesis, in
response to ligand treatment.
What triggers the LXR expression increase in the mam-
mary epithelium during lactation remains to be elucidated.
That LXR protein levels steadily increase up to peak lacta-
tion, and LXR mRNA is induced following GW3965 treat-
ment suggests its expression is likely regulated independently
of lactogenic hormones. As a consequence of the cellular
cholesterol accumulation occurring in Lac4 MECs, generation
of downstream cholesterol metabolites could build up, includ-
ing the endogenous ligands LXR, oxysterols. Of note, the
murine Lxr gene was shown to be auto regulated in adipose
tissue via an LXRE motif present in the mouse Lxr promoter
that is conserved in the human gene (54). Moreover, autoreg-
ulation of the human LXR was also described in primary
human macrophages (22, 59). Furthermore, sharp upregulation
of many cholesterol biosynthetic genes early in established
lactation (Lac4) along with increased expression of Ldlr and
Lrp8 (Fig. 1A) supports that MECs might use these proteins to
load cholesterol into the MECs following secretory activation.
Indeed, Osbpl1a was sharply induced (2.64-fold) at the transi-
tion from functional differentiation to established lactation in
isolated MECs, which is known to bind 25-hydroxycholesterol
and cholesterol (52). Therefore, we speculate the consistently
increasing LXR protein in MECs following secretory activa-
tion may represent a positive self-feedback loop to maximize
the cholesterol and fatty acid levels during peak lactation.
LXR autoregulation would be important then to increase the
levels of the receptor over a threshold necessary to induce the
batch of target genes involved in lipid transport later in lacta-
tion (54). Remarkably, the steady rise of LXR protein levels
throughout lactation mirrors the growth trajectory and subse-
quent energy demands of the growing pups.
Fig. 5. In vivo liver X receptor- (LXR) activation leads to
a significant increase in the percentage of cholesterol in milk
fat. LAC9 dams were injected intraperitoneally with GW3965
(30 mg/kg) and euthanized 24 h later. A: cholesterol milk
levels from saponified and trimethylsilyl derivatized lipids
from GW3965- or vehicle-treated dams assessed by gas chro-
matography-mass spectrometry (GC-MS). B: fatty acid methyl
esters profile quantified by GC-MS from the transmethylated
total lipid fraction, indicating that acute treatment with
GW3965 did not change the portion of de novo synthesized
medium chain fatty acids (inset) or preformed fatty acids. C:
the milk fat percent per volume (creamocrit; left) and the
%total lipid extracted (g) per wet milk mass (g) (right) were
unaffected following GW3965 treatment. NI, nonidentified.
Bars are means 
 SE (*P  0.05, n  5).
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MECs appear to have a specialized subset of LXR/RXR
target genes (i.e., Lpl, Acaca, Fasn, Cd36, and Scd1) indepen-
dent of ones identified in liver or adipose tissues (i.e., Abca1,
Abcg1, and Mylip). However, following acute GW3965 treat-
ment, there was a dramatic increase in Srebp1c levels, the
isoform most expressed in the mouse mammary gland during
pregnancy and lactation. Therefore, we cannot exclude the
possibility that Srebp1c mediates LXR dependent upregulation
of Abca7. Previous observations in bovine and goat mammary
epithelial cells treated in vitro with TO901317, an LXR syn-
thetic agonist (11, 26, 30, 36, 37, 61), demonstrated that LXR
activation increases the expression of specific ABC transport-
ers and lipogenic genes resulting in enhanced cholesterol efflux
and de novo lipogenesis. Although Abca7 expression regula-
tion was shown to be unresponsive to LXR ligands in mouse
macrophages and fibroblasts (16, 20), it can be controlled by
sterol response element-binding proteins 2 through a sterol-
responsive/regulatory element (16).
In summary, we provide new evidence that highlights the
role of LXR in controlling the cholesterol transport to the
milk and showed for the first time that in vivo activation of this
receptor modulates the levels of milk cholesterol without
affecting fatty acid profile. Although further investigation us-
ing conditional knock out of LXR during lactation would
provide valuable information, LXR/RXR arises as a key
pathway that ensures the cholesterol availability necessary for
neutral lipid packaging into CLD and free cholesterol secretion
delivered through the milk. Two major implications derive
from these findings. On one hand, LXRs are potentially attrac-
tive druggable targets for the treatment of several diseases, i.e.,
atherosclerosis, cardiovascular diseases (14) and, more impor-
tantly, mastitis (9, 15). Therefore, critical evaluation regarding
the administration of LXR agonists should be made when
designing therapies for those lactating mothers, since it could
impact the milk cholesterol composition and consequently
have implications in neonate’s development while breastfeed-
ing. On the other hand, although this study was limited by
observations at 24 h, our results could also suggest that selec-
tive LXR agonist treatment, when administered in an acute
manner, might help to overcome the difficulties that obese and
type 2 diabetic mothers experience with lactation initiation and
maintenance. Further characterization is needed to understand
if the acute GW treatment has effects at later times and in
metabolic tissues other than the lactating mammary epithelium.
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